ABBV-927

· AbbVie

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABBV-927, covering 2025-01-07 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors [Phase 1]